{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:21:50Z","timestamp":1775247710461,"version":"3.50.1"},"reference-count":41,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"unspecified","delay-in-days":9747,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[1982,11]]},"abstract":"<jats:title>Synopsis<\/jats:title><jats:p>One hundred and fifteen patients from 5 general practices participated in a 12-week, double-blind study comparing L-tryptophan, amitriptyline, L-tryptophan\u2013amitriptyline combination and placebo in the treatment of depression. Analysis of total score on the Hamilton Depression Scale and a global rating of depression showed that all 3 active treatments were more effective than placebo. Significantly more patients were withdrawn as treatment failures in the placebo group compared with the active treatment groups. Side-effects necessitated withdrawal of more patients from the amitriptyline group than from the other active tratment groups, but this difference was not significant. Plasma amitriptyline and nortriptyline levels were similar in the difference was not significant. Plasma amitriptyline and nortriptyline and biochemical profiles did not alter significantly in any group, but mean heart rate was significantly increased in patients receiving amitriptyline. There was no change in free or total plasma tryptophan concentration with treatment or on remission of symptoms.<\/jats:p>","DOI":"10.1017\/s0033291700049047","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T15:19:20Z","timestamp":1247152760000},"page":"741-751","source":"Crossref","is-referenced-by-count":150,"title":["The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo"],"prefix":"10.1017","volume":"12","author":[{"given":"Joan","family":"Thomson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. W.","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia M.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith K.","family":"McQueen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. W.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"S0033291700049047_ref041","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1976196795"},{"key":"S0033291700049047_ref040","volume-title":"Measurement and Classification of Psychiatric Symptoms","author":"Wing","year":"1974"},{"key":"S0033291700049047_ref039","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770110112012"},{"key":"S0033291700049047_ref031","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.128.1.67"},{"key":"S0033291700049047_ref022","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5857.18"},{"key":"S0033291700049047_ref021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92151-0"},{"key":"S0033291700049047_ref013","first-page":"81","article-title":"Relationships between plasma, CSF, and brain tryptophan","volume":"15","author":"Curzon","year":"1979","journal-title":"Journal of Neural Transmission"},{"key":"S0033291700049047_ref010","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750210042009"},{"key":"S0033291700049047_ref002","first-page":"277","article-title":"Effect of tryptophan infusion on plasma, CSF, and brain tryptophan in man","volume":"12","author":"Bartlett","year":"1981","journal-title":"British Journal of Clinical Pharmacology"},{"key":"S0033291700049047_ref001","first-page":"30","article-title":"Plasma tryptophan levels and mental depression in postmenopausal subjects: effects of oral piperazine oestrone sulphate","volume":"1","author":"Aylward","year":"1973","journal-title":"International Research Communications System"},{"key":"S0033291700049047_ref025","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0021-9258(18)49353-2","article-title":"The specific binding of L-tryptophan to serum albumin","volume":"233","author":"McNenamy","year":"1958","journal-title":"Journal of Biological Chemistry"},{"key":"S0033291700049047_ref036","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)91180-6"},{"key":"S0033291700049047_ref017","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"S0033291700049047_ref004","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(71)90222-1"},{"key":"S0033291700049047_ref035","first-page":"30","article-title":"Drug treatment in depressive illness (amitriptyline and chlordiazepoxide in two neurotic populations)","volume":"31","author":"Rickels","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"S0033291700049047_ref008","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1979.tb04482.x"},{"key":"S0033291700049047_ref026","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"key":"S0033291700049047_ref032","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.128.3.255"},{"key":"S0033291700049047_ref023","first-page":"441","article-title":"Amitriptyline plasma levels and clinical response in primary depression","volume":"2","author":"Kupfer","year":"1978","journal-title":"Communications in Psychopharmacology"},{"key":"S0033291700049047_ref020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-3565(25)25679-8","article-title":"A fluorimetric procedure for the estimation of tryptamine in tissues","volume":"127","author":"Hess","year":"1959","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"S0033291700049047_ref029","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421216"},{"key":"S0033291700049047_ref037","volume-title":"S.A.S. User's Guide"},{"key":"S0033291700049047_ref019","doi-asserted-by":"publisher","DOI":"10.1017\/S003329170001833X"},{"key":"S0033291700049047_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)93259-5"},{"key":"S0033291700049047_ref030","first-page":"135","article-title":"Mianserin in the treatment of depression in general practice","volume":"217","author":"Murphy","year":"1976","journal-title":"Practitioner"},{"key":"S0033291700049047_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)91096-2"},{"key":"S0033291700049047_ref015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/ajp.132.2.180","article-title":"Affective disorder: studies with amine precursors","volume":"132","author":"Dunner","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700049047_ref038","volume-title":"Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders","author":"Spitzer","year":"1977"},{"key":"S0033291700049047_ref034","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6007.460-b"},{"key":"S0033291700049047_ref028","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6158.230-a"},{"key":"S0033291700049047_ref014","doi-asserted-by":"crossref","unstructured":"Duncan D. B. (1955). Multiple range and multiple Ftests. Biometrics 03, 1\u201342.","DOI":"10.2307\/3001478"},{"key":"S0033291700049047_ref033","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5699.773"},{"key":"S0033291700049047_ref027","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760190024002"},{"key":"S0033291700049047_ref003","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5741.133"},{"key":"S0033291700049047_ref006","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.127.7.872"},{"key":"S0033291700049047_ref009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)91894-6"},{"key":"S0033291700049047_ref012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)90003-X"},{"key":"S0033291700049047_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)91031-8"},{"key":"S0033291700049047_ref016","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb00516.x"},{"key":"S0033291700049047_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90936-2"},{"key":"S0033291700049047_ref024","doi-asserted-by":"publisher","DOI":"10.1159\/000467985"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291700049047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T21:11:54Z","timestamp":1739221914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291700049047\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,11]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1982,11]]}},"alternative-id":["S0033291700049047"],"URL":"https:\/\/doi.org\/10.1017\/s0033291700049047","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,11]]}}}